Dr. Antonio Uccelli discusses the possible near-term treatment future of patients with multiple sclerosis while at ECTRIMS 2015 in Barcelona, Spain, highlighting efforts to personalize each patient’s therapy based on MRI status and use of biomarkers as a means to select evidence-based approaches designed to maximize neuroprotection and reduce the realities of disability and brain atrophy.
This interview is supported by an educational grant from Merck KGaA, Darmstadt, Germany.
Facebook Comments